Myelodysplastic syndrome physical examination

Revision as of 13:23, 29 November 2018 by Amandeep Singh (talk | contribs) (→‎Physical Examination)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Myelodysplastic syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Myelodysplastic syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Myelodysplastic syndrome physical examination On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Myelodysplastic syndrome physical examination

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Myelodysplastic syndrome physical examination

CDC on Myelodysplastic syndrome physical examination

Myelodysplastic syndrome physical examination in the news

Blogs on Myelodysplastic syndrome physical examination

Directions to Hospitals Treating Myelodysplastic syndrome

Risk calculators and risk factors for Myelodysplastic syndrome physical examination

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]

Overview

Common physical examination findings of myelodysplastic syndrome include pallor, hepatomegaly, splenomegaly, lymphadenopathy, fever, petechiae, and purpura.[1][2]

Physical Examination

Common physical examination findings of myelodysplastic syndrome include:[1][2]

Vital Signs

Skin

Neck

Abdomen


References

  1. 1.0 1.1 Clinical features of myelodysplastic syndromes. National Cancer Institute (2015). http://www.cancer.gov/types/myeloproliferative/patient/myelodysplastic-treatment-pdq. Accessed on December 13, 2015
  2. 2.0 2.1 Mutlu, Hasan; Akca, Zeki; Uskudar Teke, Havva; Ugur, Hediye (2011). "Evaluation of Peripheral Blood Smear for Myelodysplasia in Breast Cancer Patients who Received Adjuvant Antracycline". The Eurasian Journal of Medicine. 42 (3): 173–176. doi:10.5152/eajm.2011.36. ISSN 1308-8734.


Template:WikiDoc Sources